Healios K.K. (OTCMKTS:HLOSF) Sees Large Increase in Short Interest

Healios K.K. (OTCMKTS:HLOSF) saw a significant growth in short interest in October. As of October 15th, there was short interest totalling 50,500 shares, a growth of 4,490.9% from the September 30th total of 1,100 shares. Based on an average trading volume of 200 shares, the short-interest ratio is presently 252.5 days.

Healios K.K. Trading Down 6.3 %

Shares of OTCMKTS HLOSF opened at 1.50 on Friday. Healios K.K. has a one year low of 0.93 and a one year high of 1.73. The firm’s 50 day simple moving average is 1.59 and its two-hundred day simple moving average is 1.26.

Healios K.K. Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.